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This sizeable collective volume 1s perhaps the most extensive 
to date on the design of drugs m the form of inhibitors of 
selected target enzyme(s) in a metabolic chain. Its appearance 
follows by a year the recognition accorded to several of us 
pioneers by the award of the Nobel prize m physiology and 
medicine to George Hitchmgs, Gertrude Ehon and James 
Black. In fact Hitchings 1s a co-author of one of the con- 
trrbutrons, dealmg with ‘Selective Inhibition of Dihydrofolate 
Reduction’. 
An mtroductory chapter by the Editors, describing the 
general prmcrples underlying the use of enzyme inhibitors as 
drugs, is followed by 5 sub-chapters, each of which discusses 
approaches to the design of different types of Inhibitors, such 
as transition-state analogue inhibitors, active site-directed 
irreversible inhibitors, mechanism-based mhrbrtors, the now 
widespread use of molecular graphrcs systems, and the 
applicatron of quantitative structure-activity relatronshrps 
(QSAR). Conspicuously lackmg, however, is a section on the 
rapidly developmg field of molecular dynamics 
The foregoing are, in turn, succeeded by 20 chapters, each 
devoted to the design of mhrbitors of a specific enzyme, or 
class of enzymes, and, m numerous instances, including a 
survey of their relevance to chmcal applications. The chapter 
on protemase inhibitors is particularly extensive, with 4 sub- 
sections on different types of protemases. 
There 1s a chapter devoted to mhrbitors of the ‘de novo 
pyrimrdme pathway’, and another to inhibitors of purine 
biosynthesis; but both of these are more extensive than 
implied by therr titles, and include nucleoside and nucleotide 
analogue inhibitors. However, there is no coverage of 
inhibitors of nucleic acid polymerases, m particular viral 
polymerases which are currently the focus of widespread 
interest, e.g. acyclovrr, the trrphosphate of which is a selective 
inhibitor of herpes DNA polymerase; and dideoxynucleosides 
(such as AZT), which are selectrve inhibitors of the reverse 
transcrrptase of HIV (human immunodeficiency virus), both 
with significant clinical utility. 
Somewhat drsconcertmg 1s the surprising number of errors 
m structural formulae, e.g. in fig. 13.1 (p. 381), urrdine- 
5 ‘-monophosphate lacks the C(2)-carbonyl, and thymrdine- 
5 ‘-monophosphate is shown as the rrbose analogue. On 
p. 393, Z-fluorouracrl 1s shown m the drenol form, corrected 
alongside to the correct diketo form in what 1s purported to 
be 5_FdUMP, but actually shown as the ribose analogue. On 
p. 391, allopurmol and oxypurinol are both mcorrectly 
depicted m the enol form, while pyrazofurin and its 
5 ‘-phosphate both lack an essential hydrogen on a rmg 
nitrogen. On p. 773, allopurinol is again shown in the enol 
form, and oxypurinol as the enol form of the C(6)-isomer of 
allopurinol; equation 22C.l on the same page depicts 
oxypurinol as the 4-ketod-hydroxy tautomer. On p. 394, the 
quinazoline ring of a methotrexate analogue is shown in the 
enol form, whereas on p 395 another analogue 1s in the keto 
form. 
At the listed price, there ~111 probably be few takers. But 
the wealth of material it contains suggests that it may be a 
useful library reference text. 
David Shugar 
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In recent years, studies of protein biosynthesis have con- 
centrated increasingly on the questron of how proteins find 
their way to specific locatrons inside or outside the cell either 
during synthesis or shortly after completron of the 
polypeptide chain. It has become apparent that the pathways 
involved m thus process of protein targeting are also related 
to cotranslational and postranslational modifications of the 
polypeptrde chain and both processes are determmed 
essentially by the amino acid sequence of the primary, 
genetically encoded polypeptrde chain as synthesized on 
rrbosomes and by the location of enzymes and other 
components needed either for transfer of the protein across 
membranes or retention within particular cell compartments. 
The mam arm of Protezn Turgetzng is to emphasize general 
prmcrples and to compare srmrlarrties and differences among 
protein targeting pathways of prokaryotes and eukaryotes. 
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